Medication info
Pitastin Tablet 2 mg (Pitavastatin Calcium)

Pitastin Tablet 2 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Very light yellowish-red round film-coated tablet with a dividing line
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201701318 · Approved 2017.03.17 · Insurance code 656004470

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Depending on LDL-cholesterol levels, treatment goals, and patient response, the dose may be adjusted as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued use.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial dyslipidemia
  • non-familial dyslipidemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL-cholesterol
  • Apo-B protein
  • triglyceride levels
View approved original text

This medication is used as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia. It helps to reduce total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels. It also increases good cholesterol, HDL-cholesterol, thereby improving the balance of blood lipids. This contributes to reducing the risk of cardiovascular diseases caused by dyslipidemia. It is used as a therapeutic adjunct to help overall management of blood lipids.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Depending on LDL-cholesterol levels, treatment goals, and patient response, the dose may be adjusted as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued use.

Precautions

This medication should not be used in certain patients. For example, individuals with a history of allergic reactions to this drug, those with liver problems or persistently elevated liver function test results, and those with severe liver disease or bile duct obstruction should not use it. Additionally, it should not be used in patients taking cyclosporine, those with myopathies, pregnant or potentially pregnant women, breastfeeding women, and children. Patients with renal impairment or a history of liver disease, individuals who consume alcohol excessively, the elderly, patients with hypothyroidism, and those with muscle-related diseases or family history should exercise caution when using this medication. While taking this medication, unusual symptoms such as myalgia, weakness, abdominal pain, rash, or itching may occur, and liver function test results may rise, necessitating regular monitoring. In particular, if there is severe pain or weakness in the muscles, or if blood tests indicate elevated muscle enzyme levels, the use of this medication should be discontinued immediately and the physician consulted. This drug can interact with other medications, so caution is warranted, particularly when taken with cyclosporine, fibrates, niacin, and erythromycin. Consultation with a doctor or pharmacist is essential. Women who are pregnant or breastfeeding should not use this medication, and women who might become pregnant should confirm their pregnancy status before taking it. Safety and efficacy in children have not been established, so it is not used in this population. This medication should be stored out of reach of children and is safest when kept in its original container. Lastly, the elderly may experience adverse reactions more easily when taking this drug, necessitating dosage adjustments and careful monitoring.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • fatigue
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 79 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heavy head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastrointestinal discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • malaise
  • positive antinuclear antibodies
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular muscle weakness
  • facial swelling
  • arm swelling
  • hypersensitivity
  • skin tingling
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be light sensitive, so it should be stored in special containers that block light. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Very light yellowish-red round film-coated tablet with a dividing line

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.